Clinical Research Facility
Pinehurst, North Carolina 28374
We've found
9 trials
at this facility
Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Dimethyl Fumarate (DMF) Observational Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Nasal Polyposis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Updated: 12/31/1969
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Previously Treated Non Small Cell Lung Cancer Clinical Trial
Updated: 4/21/2015
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling,
Phase
II
Updated: 4/21/2015
Click here to add this to my saved trials
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Clinical Trial
Updated: 4/10/2015
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Status: Enrolling,
Phase
II
Updated: 4/10/2015
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials